- Home
- LTRN vs SRZN Comparison
LTRN vs SRZN Comparison
Compare LTRN & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- SRZN
- Stock Information
- Founded
- LTRN 2013
- SRZN 2015
- Country
- LTRN United States
- SRZN United States
- Employees
- LTRN N/A
- SRZN N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- LTRN Health Care
- SRZN Health Care
- Exchange
- LTRN Nasdaq
- SRZN Nasdaq
- Market Cap
- LTRN 36.2M
- SRZN 38.1M
- IPO Year
- LTRN 2020
- SRZN N/A
- Fundamental
- Price
- LTRN $2.99
- SRZN $9.30
- Analyst Decision
- LTRN Hold
- SRZN
- Analyst Count
- LTRN 1
- SRZN 0
- Target Price
- LTRN N/A
- SRZN N/A
- AVG Volume (30 Days)
- LTRN 50.0K
- SRZN 33.9K
- Earning Date
- LTRN 11-07-2024
- SRZN 11-06-2024
- Dividend Yield
- LTRN N/A
- SRZN N/A
- EPS Growth
- LTRN N/A
- SRZN N/A
- EPS
- LTRN N/A
- SRZN N/A
- Revenue
- LTRN N/A
- SRZN $10,000,000.00
- Revenue This Year
- LTRN N/A
- SRZN N/A
- Revenue Next Year
- LTRN N/A
- SRZN N/A
- P/E Ratio
- LTRN N/A
- SRZN N/A
- Revenue Growth
- LTRN N/A
- SRZN N/A
- 52 Week Low
- LTRN $2.79
- SRZN $6.00
- 52 Week High
- LTRN $11.99
- SRZN $16.19
- Technical
- Relative Strength Index (RSI)
- LTRN 36.73
- SRZN 45.92
- Support Level
- LTRN $3.04
- SRZN $8.10
- Resistance Level
- LTRN $3.57
- SRZN $10.76
- Average True Range (ATR)
- LTRN 0.25
- SRZN 1.25
- MACD
- LTRN -0.05
- SRZN -0.16
- Stochastic Oscillator
- LTRN 14.81
- SRZN 22.90
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).